Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–6 of 6 results
Advanced filters: Author: "Graeme Eisenhofer" Clear advanced filters

  • A promising grading system to predict metastasis in patients with phaeochromocytoma and paraganglioma assigns risk according to selected histological and other criteria. Such risk stratification might be useful for personalized management and screening programmes, as it could limit the costs of follow-up and reduce the risk of disseminated disease.

    • Graeme Eisenhofer
    • Arthur S. Tischler
    News & Views
    Nature Reviews Endocrinology
    Volume: 10, P: 315-316

  • This Case Study illustrates some of the potential pitfalls of diagnosis and demonstrates a combination of problems of follow-up biochemical screening in a patient operated for a large pheochromocytoma at increased risk of malignant disease. The difficulty in assessing the presence of disease after initial surgical resection and reaching a diagnosis of malignancy are highlighted.

    • Jörg Singer
    • Christian A. Koch
    • Ralf Paschke
    Reviews
    Nature Reviews Endocrinology
    Volume: 7, P: 749-755

  • Surgical resection of pheochromocytoma is associated with a high risk of intraoperative hemodynamic instability owing to abrupt changes in tumoral catecholamine secretion. A study by Bruynzeel et al. has now assessed preoperative risk factors and the efficacy of presurgical treatment with two different α-adrenergic receptor antagonists.

    • Graeme Eisenhofer
    • Stefan R. Bornstein
    News & Views
    Nature Reviews Endocrinology
    Volume: 6, P: 301-302

  • Pheochromocytomas are rare, often hereditary, catecholamine producing tumors that can be difficult to diagnose and manage. This Review summarizes the recommendations for biochemical and genetic testing, localization and treatment, and is based on discussions at the First International Symposium on Pheochromocytoma, held in October 2005.

    • Karel Pacak
    • Graeme Eisenhofer
    • Arthur S Tischler
    Reviews
    Nature Clinical Practice Endocrinology & Metabolism
    Volume: 3, P: 92-102